Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype? - Wikidata - awgldk - TriplyDB

Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?

Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?

http://www.wikidata.org/entity/Q38694200

about

New Novel Treatment Approaches for Heart Failure With Reduced Ejection Fraction.

P2860

Q38837866-EBD311BF-F634-449F-92F5-21D30BD88B02

P2860

Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?

http://www.wikidata.org/entity/Q38694200

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?

@en

type

label

Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?

@en

prefLabel

Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?

@en

P1433

Q38694200-06F2A459-1A04-42F1-A188-F2B2045BE934

P1476

Q38694200-5C704ACC-3998-4E8F-8014-5461538693FF

P2093

Q38694200-83BFEB1D-7F2B-4FEC-9C0A-97B5CD272D40

Q38694200-9A959345-E98E-485C-A2C3-A6F48218464E

P2860

Q38694200-021F32AE-BEC0-4745-8B68-476ED987B278

Q38694200-099E2E14-F828-42DA-B5C9-EB05DA3A9305

Q38694200-09BCFF23-2B2C-403D-8EFD-849776FA3B5C

Q38694200-0A590483-6DA7-410D-A0F1-7E9D073467FE

Q38694200-0C2FF930-4AC3-4CD4-87D0-8EEFC3F2A63A

Q38694200-0C96234B-4A22-456F-83AF-1B1B0CA902A3

Q38694200-15E5E9B0-836F-407E-B07B-4D21EFE88345

Q38694200-1624E21B-3574-4AE2-B714-23F3A851800D

Q38694200-175C02D5-183C-4B97-8DC9-A570E4D21689

Q38694200-20F46FD6-89C7-4803-9DA2-A96D97D6E6AB

P304

Q38694200-BCCB95B5-A9F7-4E1D-A23D-ABB05B98CB2D

P31

Q38694200-83D9008D-AFF6-460B-8D59-47566E325B93

P356

Q38694200-A6A7DEB4-D38A-4AC0-BF20-64CE325BBBB7

P433

Q38694200-D6196D2C-F59D-4D43-A69E-F7412788D4EA

P478

Q38694200-F1552EA1-185B-4A13-94C7-0DCF0F1FB49E

P50

Q38694200-681F8894-0920-4274-A376-A2DE8557DBF6

Q38694200-B3705CC0-8FD3-4628-9B6D-883613B2F977

P577

Q38694200-5370A581-F75D-40E3-A3CB-0AFE4504DF2D

P698

Q38694200-8E2027E8-0FDA-4E32-B6DF-453EF0D258DD

P356

1933719115615877

P1433

Journal of Pharmacy Practice

P1476

Emerging Therapies for Acute and Chronic Heart Failure: Hope or Hype?

@en

P2093

Robert J DiDomenico

http://www.w3.org/2001/XMLSchema#string

Sarah Hanigan

http://www.w3.org/2001/XMLSchema#string

P2860

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

The neuregulin-I/ErbB signaling system in development and disease

Effect of nesiritide in patients with acute decompensated heart failure

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2-terminal 20 peptide (PAMP)

P304

46-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1933719115615877

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Robert J. DiDomenico

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26759311

http://www.w3.org/2001/XMLSchema#string